Pathogenesis and treatment of anemia in inflammatory bowel disease
- PMID: 20139387
- PMCID: PMC2817016
- DOI: 10.3324/haematol.2009.017046
Pathogenesis and treatment of anemia in inflammatory bowel disease
Figures

Comment on
-
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.Haematologica. 2010 Feb;95(2):199-205. doi: 10.3324/haematol.2009.009985. Epub 2009 Oct 8. Haematologica. 2010. PMID: 19815838 Free PMC article.
References
-
- Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23. - PubMed
-
- Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3. - PubMed
-
- Johnson D, Babele H, Johnston K, Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett. 2004;573(1–3):195–201. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical